EX-10.1






EXHIBIT 10.1




Kansas City Southern




Common Stock

($.01 par value)




ATM EQUITY OFFERINGSM SALES AGREEMENT




April 27, 2009




MERRILL LYNCH & CO.


Merrill Lynch, Pierce, Fenner & Smith




Incorporated



4 World Financial Center


New York, New York 10080



Ladies and Gentlemen:



Kansas City Southern, a Delaware corporation (the “Company”), proposes, subject to the
terms and conditions stated herein, to issue and sell from time to time through Merrill Lynch,
Pierce, Fenner & Smith Incorporated, as sales agent (the “Agent”), shares (the
“Shares”) of the Company’s common stock, $.01 par value (the “Common Stock”),
having an aggregate offering price of up to $75,000,000 on the terms set forth in Section 2 of this
ATM Equity OfferingSM Sales Agreement (the “Agreement”).



Section 1. Representations and Warranties. The Company represents and warrants to
the Agent that as of the date of this Agreement, each Suspension Termination Date (as defined in
Section 2(c) below), each Applicable Time (as defined in Section 1(a) below) and each Settlement
Date (as defined in Section 2 below) and, except during any period in which the offering of Shares
is suspended pursuant to Section 2(c), any applicable Registration Statement Amendment Date (as
defined in Section 3 below), each Company Periodic Report Date (as defined in Section 3 below) and
each Company Earnings Report Date (as defined in Section 3 below):



(a) Compliance with Registration Requirements. The Company has filed with the
Securities and Exchange Commission (the “Commission”) an “automatic shelf registration
statement” as defined under Rule 405 under the Securities Act of 1933, as amended, and the rules
and regulations of the Commission thereunder (the “1933 Act”), on Form S-3 (File No.
333-155601), relating to certain securities of the Company (including the Shares) (collectively,
the “Securities”) not earlier than three years prior to the date hereof; such registration
statement, and any post-effective amendment thereto, became effective on filing; and no stop order
suspending the effectiveness of such registration statement or any part thereof has been issued and
no proceeding for that purpose has been initiated or, to the knowledge of the Company, threatened
by the Commission, and no notice of objection of the Commission to the use of such form of
registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the
1933 Act has been received by the Company (the base prospectus filed as part of such registration
statement, in the form in which it has most recently been filed with the Commission on or prior to
the date of this Agreement, is hereinafter called the “Basic Prospectus”; the various parts
of such registration statement, excluding any Form T-1 but including all exhibits thereto and any
prospectus supplement relating to the Shares that is filed with the Commission and deemed by virtue
of Rule 430B to be part of such registration statement, each as amended at the time such part of
the registration statement became effective, are hereinafter collectively called the
“Registration Statement”; the prospectus supplement specifically relating to the Shares
prepared and filed by the Company with the Commission pursuant to Rule 424(b) under the 1933 Act is
hereinafter called the “Prospectus Supplement”; the Basic Prospectus, as amended and
supplemented by the Prospectus Supplement, is hereinafter called the “Prospectus”; any
reference herein to the Basic Prospectus, the Prospectus Supplement or the Prospectus shall be
deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12
of Form S-3 under the 1933 Act; any reference to any amendment or supplement to the Basic
Prospectus, the Prospectus Supplement or the Prospectus shall be deemed to refer to and include any
post-effective amendment to the Registration Statement, any prospectus supplement relating to the
Shares filed by the Company with the Commission pursuant to Rule 424(b) under the 1933 Act and any
documents filed by the Company under the Securities Exchange Act of 1934, as amended, and the rules
and regulations of the Commission thereunder (the “1934 Act”), and incorporated therein, in
each case after the date of the Basic Prospectus, the Prospectus Supplement or the Prospectus, as
the case may be; any reference to any amendment to the Registration Statement shall be deemed to
refer to and include any annual report of the Company filed pursuant to Section 13(a) or 15(d) of
the 1934 Act after the effective date of the Registration Statement that is incorporated by
reference in the Registration Statement; and any “issuer free writing prospectus” as defined in
Rule 433 under the 1933 Act relating to the Shares is hereinafter called an “Issuer Free
Writing Prospectus”).



No order preventing or suspending the use of the Basic Prospectus, the Prospectus Supplement,
the Prospectus or any Issuer Free Writing Prospectus has been issued by the Commission, and the
Basic Prospectus and the Prospectus Supplement, at the time of filing thereof, conformed in all
material respects to the requirements of the 1933 Act and did not contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to make
the statements therein, in the light of the circumstances under which they were made, not
misleading, except that the representations and warranties set forth in this Section shall not
apply to statements or omissions based upon information relating to the Agent furnished to the
Company by the Agent in writing expressly for use in any Prospectus, Prospectus Supplement, Issuer
Free Writing Prospectus or General Disclosure Package.



For the purposes of this Agreement, the “Applicable Time” means, with respect to any
Shares, the time of sale of such Shares pursuant to this Agreement. The Prospectus and any
applicable Issuer Free Writing Prospectus(es) issued at or prior to such Applicable Time, taken
together (collectively, and, with respect to any Shares, together with the public offering price of
such Shares, the “General Disclosure Package”) as of each Applicable Time and each
Settlement Date, will not include any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading, except that the representations and warranties set
forth in this Section shall not apply to statements or omissions based upon information relating to
the Agent furnished to the Company by the Agent in writing expressly for use in any Prospectus,
Prospectus Supplement, Issuer Free Writing Prospectus or General Disclosure Package; and each
applicable Issuer Free Writing Prospectus will not conflict with the information contained in the
Registration Statement, the Prospectus Supplement or the Prospectus and each such Issuer Free
Writing Prospectus, as supplemented by and taken together with the General Disclosure Package as of
such Applicable Time, will not include any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading, except that the representations and warranties set
forth in this section shall not apply to statements or omissions based upon information relating to
the Agent furnished to the Company by the Agent in writing expressly for use in any Prospectus,
Prospectus Supplement, Issuer Free Writing Prospectus or General Disclosure Package.



(b) Incorporation of Documents by Reference. The documents incorporated or deemed to
be incorporated by reference in the Registration Statement and the Prospectus, when they became
effective or were filed with the Commission, as the case may be, complied in all material respects
with the requirements of the 1934 Act, and, when read together with the other information in the
Prospectus, (a) at the time the Registration Statement became effective, (b) at the time the
Prospectus was issued and (c) on the date of this Agreement, did not contain an untrue statement of
a material fact or omit to state a material fact required to be stated therein or necessary to make
the statements therein not misleading.



(c) Independent Accountants. The accountants who certified the financial statements
and supporting schedules included in the Registration Statement are independent public accountants
with respect to the Company as required by the 1933 Act and the 1933 Act Regulations.



(d) Financial Statements. The historical audited consolidated financial statements
and notes of the Company included or incorporated by reference in the Registration Statement, the
General Disclosure Package and the Prospectus (i) have been prepared in accordance with U.S.
generally accepted accounting principles (“GAAP”), (ii) present fairly in all material
respects the financial condition, results of operations and cash flows of the Company and each of
its subsidiaries taken as a whole, and (iii) comply as to form in all material respects with the
applicable accounting requirements of the 1933 Act. No other financial statements are required to
be included or incorporated by reference in the Registration Statement, the General Disclosure
Package or the Prospectus.



(e) No Material Adverse Change in Business. Since the respective dates as of which
information is given in the Registration Statement, the General Disclosure Package or the
Prospectus, except as otherwise stated therein, there has not occurred any material adverse change,
or to the Company’s knowledge, any development involving a prospective material adverse change, in
the condition, financial or otherwise, or in the earnings, business affairs or operations of the
Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary
course of business (a “Material Adverse Effect”).



(f) Good Standing of the Company. The Company has been duly incorporated, is validly
existing as a corporation in good standing under the laws of the jurisdiction of its incorporation,
has the corporate power and authority to own, lease and operate its property and to conduct its
business as described in the Prospectus and is duly qualified to transact business and is in good
standing in each jurisdiction in which the conduct of its business or its ownership or leasing of
property requires such qualification, except to the extent that the failure to be so qualified or
be in good standing would not result in a Material Adverse Effect.



(g) Good Standing of Subsidiaries. Each subsidiary of the Company has been duly
organized, is validly existing and in good standing (to the extent applicable) under the laws of
the jurisdiction of its organization, has the power and authority to own, lease and operate its
property and to conduct its business as described in the Prospectus and is duly qualified to
transact business and is in good standing (to the extent applicable) in each jurisdiction in which
the conduct of its business or its ownership or leasing of property requires such qualification,
except to the extent that the failure to be so qualified or be in good standing (to the extent
applicable) would not have a Material Adverse Effect; all of the issued shares of capital stock of
each corporate subsidiary of the Company held by the Company have been duly and validly authorized
and issued, are fully paid and non-assessable and are owned directly or indirectly by the Company
free and clear of all liens, encumbrances, equities or claims.



(h) Capitalization. The authorized, issued and outstanding capital stock of the
Company is as set forth in the Registration Statements and the Prospectus in the column entitled
“Actual” under the caption “Capitalization” (except for subsequent issuances, if any, pursuant to
this Agreement, pursuant to reservations, agreements or employee benefit plans referred to in the
Prospectus or pursuant to the exercise of convertible securities or options referred to in the
Prospectus). The shares of issued and outstanding Common Stock have been duly authorized and
validly issued and are fully paid and non-assessable; none of the outstanding shares of capital
stock was issued in violation of the preemptive or other similar rights of any securityholder of
the Company. The Company’s Common Stock has been registered pursuant to Section 12(b) of the 1934
Act and is listed on the New York Stock Exchange (the “NYSE”), and the Company has taken no
action designed to, or likely to have the effect of, terminating the listing of the Common Stock
from the NYSE, nor has the Company received any notification that the Commission or the NYSE is
contemplating terminating such registration or listing.



(i) Authorization of Agreement. This Agreement has been duly authorized, executed and
delivered by the Company.



(j) Authorization and Description of Securities. The Shares have been duly authorized
and reserved for issuance and sale pursuant to this Agreement and, when issued and delivered by the
Company pursuant to this Agreement against payment of the consideration set forth herein, will be
validly issued and fully paid and non-assessable; the Common Stock conforms as to legal matters to
the description thereof contained in the Prospectus and such description conforms in all material
respects to the rights set forth in the instruments defining the same; no holder of the Shares will
be subject to personal liability by reason of being such a holder; and the issuance of the Shares
is not subject to the preemptive or other similar rights of any securityholder of the Company.



(k) Absence of Defaults and Conflicts. Neither the Company nor any of its
subsidiaries is in violation of its charter or by-laws or in default in the performance or
observance of any obligation, agreement, covenant or condition contained in any contract,
indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or
instrument to which the Company or any of its subsidiaries is a party or by which it or any of them
may be bound, or to which any of the property or assets of the Company or any subsidiary is subject
except for such defaults that would not have a Material Adverse Effect; and the execution, delivery
and performance of this Agreement and the consummation of the transactions contemplated herein and
in the Registration Statement (including the issuance and sale of the Shares and the use of the
proceeds from the sale of the Shares as described in the Prospectus under the caption “Use of
Proceeds”) and compliance by the Company with its obligations hereunder have been duly authorized
by all necessary corporate action and do not and will not (i) contravene any provision of
applicable law or the certificate of incorporation or by-laws of the Company or any agreement or
other instrument binding upon the Company or any of its subsidiaries included or incorporated by
reference in the Company’s most recent Annual Report on Form 10-K, (ii) result in an event or
condition which gives the holder of any notes, debenture, or other evidence of indebtedness
included or incorporated by reference in the Company’s most recent Annual Report on Form 10-K (or
any person acting on such holder’s behalf) the right to require the repurchase, redemption or
repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries, or
(iii) contravene, conflict with or constitute a breach of, or default under any judgment, order or
decree of any governmental body, agency or court having jurisdiction over the Company or any of its
subsidiaries and their respective operations, except to the extent that such contravention,
violation, breach or default described in item (iii) above would not have a Material Adverse
Effect.



(l) Absence of Labor Dispute. Except as described in the Registration Statement, no
material labor dispute with the employees of the Company or any of its subsidiaries exists or, to
the knowledge of the Company or any of its subsidiaries, is threatened or, to the knowledge of the
Company, is imminent, and to the knowledge of the Company and any of its subsidiaries there is no
existing or imminent labor disturbance by the employees of any of their respective principal
suppliers, contractors or customers that would be reasonably likely to have a Material Adverse
Effect.



(m) Absence of Proceedings. There are no legal or governmental proceedings pending
or, to the Company’s knowledge, threatened to which the Company or any of its subsidiaries is a
party or to which any of the properties of the Company or any of its subsidiaries is subject (i)
other than proceedings that are accurately described in all material respects in the Registration
Statement and proceedings that would not have a Material Adverse Effect, or on the power or ability
of the Company to perform its obligations under this Agreement or to consummate the transactions
contemplated by this Agreement or (ii) that are required to be described in the Registration
Statement by Regulation S-K or the item requirements of the applicable form under the 1933 Act or
the 1934 Act and are not so described.



(n) Disclosure of Statutes and Contracts, Etc. There are no statutes, regulations,
contracts or other documents that are required to be described in the Registration Statement, the
Prospectus or the documents incorporated by reference therein by Regulation S-K or the item
requirements of the applicable form under the 1933 Act or the 1934 Act or to be filed as exhibits
thereto that are not described or filed as required.



(o) Absence of Further Requirements. No filing with, or authorization, approval,
consent, license, order, registration, qualification or decree of, any court or governmental
authority or agency is necessary or required for the performance by the Company of its obligations
hereunder, in connection with the offering, issuance or sale of the Securities hereunder or the
consummation of the transactions contemplated by this Agreement, except such as have been already
obtained or as may be required under the 1933 Act or the 1933 Act Regulations or state securities
laws.



(p) Absence of Manipulation. Neither the Company nor any affiliate of the Company has
taken, nor will the Company or any affiliate take, directly or indirectly, any action which is
designed to or which has constituted or which would reasonably be expected to cause or result in
stabilization or manipulation of the price of any security of the Company to facilitate the sale or
resale of the Shares.



(q) Possession of Licenses and Permits. The Company and each of its subsidiaries own,
possess or has obtained all licenses, permits, certificates, consents, orders, approvals and other
authorizations from, and has made all declarations and filings with, all federal, state, local and
other governmental authorities (including foreign regulatory agencies), all self-regulatory
organizations and all courts and other tribunals, domestic or foreign, necessary to own or lease,
as the case may be, and to operate their properties and to carry on their business as conducted as
of the date hereof and as described in the Registration Statement, except to the extent that the
failure to own, possess or obtain such licenses, permits, certificates, consents, orders, approvals
and other authorizations would not have a Material Adverse Effect; and neither the Company nor any
of its subsidiaries has received any notice of any proceeding relating to revocation or
modification of any such license, permit, certificate, consent, order, approval or other
authorization which, individually or in the aggregate, if the subject of an unfavorable or adverse
decision or ruling, would reasonably be expected to result in a Material Adverse Effect.



(r) Investment Company Act. The Company is not required, and upon the issuance and of
the Shares as herein contemplated and the application of the net proceeds therefrom as described in
the Prospectus will not be required, to register as an “investment company” within the meaning of
the Investment Company Act of 1940, as amended (the “1940 Act”).



(s) Environmental Laws. The Company and its subsidiaries (i) are in
compliance with any and all applicable foreign, federal, state and local laws and regulations
relating to the protection of human health and safety, the environment or hazardous or toxic
substances or wastes, pollutants or contaminants (“Environmental Laws”), (ii)
have received all permits, licenses or other approvals required of them under applicable
Environmental Laws to conduct their respective businesses and (iii) are in compliance
with all terms and conditions of any such permit, license or approval, except, in each case, where
such noncompliance with Environmental Laws, failure to receive required permits, licenses or other
approvals or failure to comply with the terms and conditions of such permits, licenses or approvals
would not, singly or in the aggregate, have a Material Adverse Effect. There are no costs or
liabilities associated with Environmental Laws (including, without limitation, any capital or
operating expenditures required for clean-up, closure of properties or compliance with
Environmental Laws or any permit, license or approval, any related constraints on operating
activities and any potential liabilities to third parties) which would, singly or in the aggregate,
have a Material Adverse Effect.



(t) Registration Rights. There are no persons with registrations rights or other
similar rights to have any securities registered pursuant to the Registration Statement or
otherwise registered by the Company under the 1933 Act.



(u) Accounting Controls. The Company and each of its subsidiaries maintain a system
of internal accounting controls sufficient to provide reasonable assurance that (A) transactions
are executed in accordance with management’s general or specific authorizations; (B) all
transactions are recorded as necessary to permit preparation of financial statements in GAAP and to
maintain asset accountability; (C) access to assets is permitted only in accordance with
management’s general or specific authorization; and (D) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action is taken with
respect to any differences.



(v) Well-Known Seasoned Issuer. (A)(i) At the time of filing the Registration
Statement, (ii) at the time of the most recent amendment thereto for the purposes of complying with
Section 10(a)(3) of the 1933 Act (whether such amendment was by post-effective amendment,
incorporated report filed pursuant to Section 13 or 15(d) of the 1934 Act or form of prospectus),
and (iii) at the time the Company or any person acting on its behalf (within the meaning, for this
clause only, of Rule 163(c) under the 1933 Act) made any offer relating to the Shares in reliance
on the exemption of Rule 163 under the 1933 Act, the Company was a “well-known seasoned issuer” as
defined in Rule 405 under the 1933 Act; and (B) at the earliest time after the filing of the
Registration Statement that the Company or another offering participant made a bona fide offer
(within the meaning of Rule 164(h)(2) under the 1933 Act) of the Shares, the Company was not an
“ineligible issuer” as defined in Rule 405 under the 1933 Act.



(w) No Commissions. Neither the Company nor any of its subsidiaries is a party to any
contract, agreement or understanding with any person (other than as contemplated by this Agreement)
that would give rise to a valid claim against the Company or any of its subsidiaries or the Agent
for a brokerage commission, finder’s fee or like payment in connection with the offering and sale
of the Shares.



(x) Actively-Traded Security. The Common Stock is an “actively-traded security”
exempted from the requirements of Rule 101 of Regulation M under the 1934 Act by subsection (c)(1)
of such rule.



(y) Deemed Representation. Any certificate signed by any officer of the Company
delivered to the Agent or to counsel for the Agent pursuant to or in connection with this Agreement
shall be deemed a representation and warranty by the Company to the Agent as to the matters covered
thereby as of the date or dates indicated in such certificate.



(z) Compliance with the Sarbanes-Oxley Act. There is and has been no failure on the
part of the Company and, to the Company’s knowledge, any of the Company’s directors or officers, in
their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002 and the
rules and regulations promulgated in connection therewith (the “Sarbanes-Oxley Act”)
applicable to the Company as of the date hereof.



(aa) Payment of Taxes. The Company and each of its subsidiaries has filed all tax
returns (foreign, national, local or other) required to be filed and has paid all taxes required to
be paid by them and any other assessment, fine or penalty levied against them, to the extent that
any of the foregoing is due and payable, except for any such assessment, fine or penalty that is
currently being contested in good faith and except where the failure to file or pay would not,
individually or in the aggregate, result in a Material Adverse Effect.



(bb) Insurance. The Company and each of its subsidiaries is insured by insurers of
recognized financial responsibility against such losses and risks and in such amounts as are
prudent and customary for companies engaged in the same or similar businesses; all such policies
covering any of their business, assets, employees, officers and directors are in full force and
effect; the Company and each of its subsidiaries is in compliance with the terms of such policies
and instruments in all material respects, and there are no claims by the Company or any of its
subsidiaries under any such policy or instrument as to which any insurance company is denying
liability of defending under a reservation of rights clause; and neither the Company nor any of its
subsidiaries has any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as
may be necessary to continue in their businesses.



(cc) Unlawful Payments. Neither the Company nor any of its subsidiaries or
affiliates, nor to the knowledge of the Company, any director, officer, employee, agent or
representative of the Company or of any of its subsidiaries or affiliates, has taken or will take
any action in furtherance of an offer, payment, promise to pay, or authorization or approval of the
payment or giving of money, property, gifts or anything else of value, directly or indirectly, to
any “government official” (including any officer or employee of a government or government-owned or
controlled entity or of a public international organization, or any person acting in an official
capacity for or on behalf of any of the foregoing, or any political party or party official or
candidate for political office) to influence official action or secure an improper advantage; and
the Company and its subsidiaries and affiliates have conducted their businesses in compliance with
applicable anti-corruption laws and have instituted and maintain and will continue to maintain
policies and procedures designed to promote and achieve compliance with such laws and with the
representation and warranty contained herein.



(dd) Money Laundering Laws. The operations of the Company and its domestic
subsidiaries are and have been conducted at all times in material compliance with all applicable
financial recordkeeping and reporting requirements, including those of the Bank Secrecy Act, as
amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools
Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and the applicable
anti-money laundering statutes of jurisdictions where the Company and its subsidiaries conduct
business, the rules and regulations thereunder and any related or similar rules, regulations or
guidelines, issued, administered or enforced by any governmental agency (collectively, the
“Anti-Money Laundering Laws”), and no action, suit or proceeding by or before any court or
governmental agency, authority or body or any arbitrator involving the Company or any of its
subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the
Company, threatened.



(ee) OFAC. (i) The Company represents that neither it nor any of its domestic
subsidiaries (collectively, the “Entity”) or, to the knowledge of the Entity, any director,
officer, employee, agent, affiliate or representative of the Entity, is an individual or entity
(“Person”) that is, or is owned or controlled by a Person that is:




(A) the subject of any sanctions administered or enforced by the U.S.
Department of Treasury’s Office of Foreign Assets Control (“OFAC”) or other
relevant sanctions authority (collectively, “Sanctions”), nor




(B) located, organized or resident in a country or territory that is the
subject of Sanctions (including, without limitation, Burma/Myanmar, Cuba, Iran,
North Korea, Sudan and Syria).



(ii) The Entity represents and covenants that it will not, directly or indirectly, use the
proceeds of the offering of Shares, or lend, contribute or otherwise make available such proceeds
to any subsidiary, joint venture partner or other Person:




(A) to fund or facilitate any activities or business of or with any Person or
in any country or territory that, at the time of such funding or facilitation, is
the subject of Sanctions; or




(B) in any other manner that will result in a violation of Sanctions by any
Person (including any Person participating in the offering, whether as underwriter,
advisor, investor or otherwise).



(iii) The Entity represents and covenants that it has not knowingly engaged in, and will not
engage in, any dealings or transactions with any Person, or in any country or territory, that at
the time of the dealing or transaction is or was the subject of Sanctions.



(ff) No Relationships. No relationship, direct or indirect, exists between
the Company or any of its subsidiaries on the one hand, and the directors, officers, stockholders,
customers or suppliers of the Company or any of its subsidiaries on the other hand, which is
required by the 1933 Act to be described in the Prospectus which is not so described.



(gg) Title to Property. The Company and its subsidiaries have good and marketable
title to all real property owned by the Company and its subsidiaries and good title to all other
properties owned by them, in each case, free and clear of all mortgages, pledges, liens, security
interests, claims, restrictions or encumbrances of any kind except such as (a) are described in the
Prospectus or (b) do not, singly or in the aggregate, materially affect the value of such property
and do not interfere with the use made and proposed to be made of such property by the Company or
any of its subsidiaries; and all of the leases and subleases material to the business of the
Company and its subsidiaries, considered as one enterprise, and under which the Company or any of
its subsidiaries holds properties described in the Prospectus, are in full force and effect, and
neither the Company nor any subsidiary has any notice of any material claim of any sort that has
been asserted by anyone adverse to the rights of the Company or any subsidiary under any of the
leases or subleases mentioned above, or affecting or questioning the rights of the Company or such
subsidiary to the continued possession of the leased or subleased premises under any such lease or
sublease.



Section 2. Sale and Delivery of Shares.



(a) Subject to the terms and conditions set forth herein, the Company agrees to issue and sell
through the Agent acting as sales agent from time to time, and the Agent agrees to use commercially
reasonable efforts to sell as sales agent for the Company, the Shares. Sales of the Shares, if
any, through the Agent acting as sales agent will be made by means of ordinary brokers’
transactions on the NYSE or otherwise at market prices prevailing at the time of sale, at prices
related to prevailing market prices or at negotiated prices.



(b) The Shares are to be sold on a daily basis or otherwise as shall be agreed to by the
Company and the Agent on any trading day (other than a day on which the NYSE is scheduled to close
prior to its regular weekday closing time, each, a “Trading Day”) that the Company has
satisfied its obligations under Section 6 of this Agreement and that the Company has instructed the
Agent to make such sales. On any Trading Day, the Company may instruct the Agent by telephone
(confirmed promptly by telecopy or email, which confirmation will be promptly acknowledged by the
Agent) as to the maximum number of Shares to be sold by the Agent on such day (in any event not in
excess of the number available for issuance under the Prospectus and the currently effective
Registration Statement) and the minimum price per Share at which such Shares may be sold. Subject
to the terms and conditions hereof, the Agent shall use commercially reasonable efforts to sell as
sales agent all of the Shares so designated by the Company. The Company and the Agent each
acknowledge and agree that (A) there can be no assurance that the Agent will be successful in
selling the Shares, (B) the Agent will incur no liability or obligation to the Company or any other
person or entity if it does not sell Shares for any reason other than a failure by the Agent to use
commercially reasonable efforts consistent with normal trading and sales practices and applicable
law and regulations to sell such Shares as required by this Agreement, and (C) the Agent shall be
under no obligation to purchase Shares on a principal basis.



(c) Notwithstanding the foregoing, the Company shall not authorize the issuance and sale of,
and the Agent as sales agent shall not be obligated to use commercially reasonable efforts to sell,
any Shares (i) at a price lower than the minimum price therefor authorized from time to time, or
(ii) in a number in excess of the number of Shares authorized from time to time to be issued and
sold under this Agreement, in each case, by the Company’s board of directors, or a duly authorized
committee thereof, and notified to the Agent in writing. In addition, the Company or the Agent
may, upon notice to the other party hereto by telephone (confirmed promptly by telecopy or email,
which confirmation will be promptly acknowledged), suspend the offering of the Shares with respect
to which the Agent is acting as sales agent for any reason and at any time; provided,
however, that such suspension or termination shall not affect or impair the parties’
respective obligations with respect to the Shares sold hereunder prior to the giving of such
notice. Each date of termination of a suspension of the offering of Shares pursuant to this
Section 2(c), if any, is herein referred to as a “Suspension Termination Date”.



(d) The gross sales price of any Shares sold pursuant to this Agreement by the Agent shall be
the market price prevailing at the time of sale for shares of the Company’s Common Stock sold by
the Agent on the NYSE or otherwise, at prices relating to prevailing market prices or at negotiated
prices. The compensation payable to the Agent for sales of Shares shall be equal to 2.00% of the
gross sales price of the Shares for amounts of Shares sold pursuant to this Agreement. The
remaining proceeds, after further deduction for any transaction fees imposed by any governmental,
regulatory or self-regulatory organization in respect of such sales, shall constitute the net
proceeds to the Company for such Shares (the “Net Proceeds”). The Agent shall notify the
Company as promptly as practicable if any deduction referenced in the preceding sentence will be
required.



(e) The Agent shall provide written confirmation to the Company following the close of
trading on the NYSE each day in which Shares are sold under this Agreement setting forth the number
of Shares sold on such day, the aggregate gross sales proceeds of the Shares, the Net Proceeds to
the Company and the compensation payable by the Company to the Agent with respect to such sales.



(f) Under no circumstances shall the aggregate offering price or number, as the case may be,
of Shares sold pursuant to this Agreement exceed the aggregate offering price or number, as the
case may be, of Shares of Common Stock (i) set forth in the preamble paragraph of this Agreement,
(ii) available for issuance under the Prospectus and the then currently effective Registration
Statement or (iii) authorized from time to time to be issued and sold under this Agreement by the
Company’s board of directors, or a duly authorized committee thereof, and notified to the Agent in
writing. In addition, under no circumstances shall any Shares be sold at a price lower than the
minimum price therefor authorized from time to time by the Company’s board of directors, or a duly
authorized committee thereof, and notified to the Agent in writing.



(g) If either party believes that the exemptive provisions set forth in Rule 101(c)(1) of
Regulation M under the 1934 Act (applicable to securities with an average daily trading volume of
$1,000,000 that are issued by an issuer whose common equity securities have a public float value of
at least $150,000,000) are not satisfied with respect to the Company or the Shares, it shall
promptly notify the other party and sales of Shares under this Agreement shall be suspended until
that or other exemptive provisions have been satisfied in the judgment of each party.



(h) Settlement for sales of Shares pursuant to this Section 2 will occur on the third business
day that is also a Trading Day following the trade date on which such sales are made, unless
another date shall be agreed to by the Company and the Agent (each such day, a “Settlement
Date”). On each Settlement Date, the Shares sold through the Agent for settlement on such date
shall be delivered by the Company to the Agent against payment of the Net Proceeds from the sale of
such Shares. Settlement for all Shares shall be effected by book-entry delivery of Shares to the
Agent’s account at The Depository Trust Company against payments by the Agent of the Net Proceeds
from the sale of such Shares in same day funds delivered to an account designated by the Company.
If the Company shall default on its obligation to deliver Shares on any Settlement Date, the
Company shall (i) indemnify and hold the Agent harmless against any loss, claim or damage arising
from or as a result of such default by the Company and (ii) pay the Agent any commission to which
it would otherwise be entitled absent such default. If the Agent breaches this Agreement by
failing to deliver the applicable Net Proceeds on any Settlement Date for Shares delivered by the
Company, the Agent will pay the Company interest based on the effective overnight federal funds
rate plus two (2.00) percentage points until such proceeds, together with such interest, have been
fully paid.



(i) Notwithstanding any other provision of this Agreement, the Company and the Agent agree
that no sales of Shares shall take place, and the Company shall not request the sale of any Shares
that would be sold, and the Agent shall not be obligated to sell, during any period in which the
Company is in possession of material non-public information. The period beginning on the last day
of any fiscal quarter and ending on the business day following the Company Earnings Report Date
relating to such fiscal quarter is referred to herein as the “Blackout Period”.



(j) At each Applicable Time, Settlement Date, Suspension Termination Date and, except during
any period in which the offering of Shares is suspended pursuant to Section 2(c), each Registration
Statement Amendment Date, each Company Periodic Report Date and each Company Earnings Report Date,
the Company shall be deemed to have affirmed each representation and warranty contained in this
Agreement. The Company shall cause a senior corporate officer of the Company from time to time
designated by the Company (which senior corporate officer shall initially be one of the senior
corporate officers specified in Exhibit A hereto) to respond via electronic mail to a communication
from the Agent in the form set forth in Exhibit A hereto when, during the term of this Agreement,
the Company shall have received such a communication. Any obligation of the Agent to use
commercially reasonable efforts to sell the Shares on behalf of the Company as sales agent shall be
subject to the continuing accuracy of the representations and warranties of the Company herein, to
the performance by the Company of its obligations hereunder and to the continuing satisfaction of
the additional conditions specified in Section 6 of this Agreement.



Section 3. Covenants. The Company agrees with the Agent:



(a) During any period when the delivery of a prospectus is required in connection with the
offering or sale of Shares (whether physically or through compliance with Rule 153 or 172, or in
lieu thereof, a notice referred to in Rule 173(a) under the 1933 Act), (i) to make no further
amendment or any supplement to the Registration Statement or the Prospectus prior to any Settlement
Date which shall be disapproved by the Agent promptly after reasonable notice thereof, provided
that, if in the opinion of counsel to the Company any such amendment or supplement shall be
required by law or regulation to be made, the Company shall be permitted to file such amendment or
supplement after taking into account such comments as the Agent may make on the form, content or
other aspects of such amendment or supplement, and to advise the Agent, promptly after it receives
notice thereof, of the time when any amendment to the Registration Statement has been filed or
becomes effective or any amendment or supplement to the Prospectus has been filed and to furnish
the Representatives with copies thereof, (ii) to file promptly all other material required to be
filed by the Company with the Commission pursuant to Rule 433(d) under the 1933 Act, (iii) to file
promptly all reports and any definitive proxy or information statements required to be filed by the
Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the 1934 Act, (iv) to
advise the Agent, promptly after it receives notice thereof, of the issuance by the Commission of
any stop order or of any order preventing or suspending the use of the Prospectus or other
prospectus in respect of the Shares, of any notice of objection of the Commission to the use of the
form of the Registration Statement or any post-effective amendment thereto pursuant to Rule
401(g)(2) under the 1933 Act, of the suspension of the qualification of the Shares for offering or
sale in any jurisdiction, of the initiation or threatening of any proceeding for any such purpose,
or of any request by the Commission for the amending or supplementing of the form of the
Registration Statement or the Prospectus or for additional information, and (v) in the event of the
issuance of any such stop order or of any such order preventing or suspending the use of the
Prospectus in respect of the Shares or suspending any such qualification, to promptly use
commercially reasonable efforts to obtain the withdrawal of such order; and in the event of any
such issuance of a notice of objection, promptly to take such reasonable steps as may be necessary
to permit offers and sales of the Shares by the Agent, which may include, without limitation,
amending the Registration Statement or filing a new registration statement, at the Company’s
expense (references herein to the Registration Statement shall include any such amendment or new
registration statement).



(b) Promptly from time to time to take such action as the Agent may reasonably request to
qualify the Shares for offering and sale under the securities laws of such jurisdictions as the
Agent may request and to comply with such laws so as to permit the continuance of sales and
dealings therein in such jurisdictions for as long as may be necessary to complete the sale of the
Shares, provided that in connection therewith the Company shall not be required to qualify as a
foreign corporation or to file a general consent to service of process in any jurisdiction; and to
promptly advise the Agent of the receipt by the Company of any notification with respect to the
suspension of the qualification of the Shares for offer or sale in any jurisdiction or the
initiation or threatening of any proceeding for such purpose.



(c) During any period when the delivery of a prospectus is required (whether physically or
through compliance with Rules 153 or 172, or in lieu thereof, a notice referred to in Rule 173(a)
under the 1933 Act) in connection with the offering or sale of Shares, the Company will make
available to the Agent, as soon as practicable after the execution of this Agreement, and
thereafter from time to time furnish to the Agent, copies of the most recent Prospectus in such
quantities and at such locations as the Agent may reasonably request for the purposes contemplated
by the 1933 Act. During any period when the delivery of a prospectus is required (whether
physically or through compliance with Rules 153 or 172, or in lieu thereof, a notice referred to in
Rule 173(a) under the 1933 Act) in connection with the offering or sale of Shares, and if at such
time any event shall have occurred as a result of which the Prospectus as then amended or
supplemented would include an untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the circumstances under
which they were made when such Prospectus is delivered, not misleading, or, if for any other reason
it shall be necessary during such same period to amend or supplement the Prospectus or to file
under the 1934 Act any document incorporated by reference in the Prospectus in order to comply with
the 1933 Act or the 1934 Act, to notify the Agent and to file such document and to prepare and
furnish without charge to the Agent as many written and electronic copies as the Agent may from
time to time reasonably request of an amended Prospectus or a supplement to the Prospectus which
will correct such statement or omission or effect such compliance.



(d) To make generally available to its securityholders as soon as practicable, but in any
event not later than sixteen months after the effective date of the Registration Statement (as
defined in Rule 158(c) under the 1933 Act), an earnings statement of the Company and its
subsidiaries (which need not be audited) complying with Section 11(a) of the 1933 Act and the rules
and regulations of the Commission thereunder (including, at the option of the Company, Rule 158).



(e) To pay the required Commission filing fees relating to the Shares within the time required
by Rule 456(b)(1) under the 1933 Act without regard to the proviso therein and otherwise in
accordance with Rules 456(b) and 457(r) under the 1933 Act.



(f) To use the Net Proceeds received by it from the sale of the Shares pursuant to this
Agreement in the manner specified in the applicable General Disclosure Package.



(g) In connection with the offering and sale of the Shares, the Company will file with the
NYSE all documents and notices, and make all certifications, required by the NYSE of companies that
have securities that are listed on the NYSE and will maintain such listing.



(h) To not take, directly or indirectly, any action designed to cause or result in, or that
has constituted or might reasonably be expected to constitute, under the 1934 Act or otherwise, the
stabilization or manipulation of the price of any securities of the Company to facilitate the sale
or resale of the Shares.



(i) At each Applicable Time, each Settlement Date, each Suspension Termination Date, and,
except during any period in which the offering of Shares is suspended pursuant to Section 2(c),
each Registration Statement Amendment Date (as defined below), each Company Earnings Report Date
(as defined below) and each Company Periodic Report Date (as defined below), the Company shall be
deemed to have affirmed each representation, warranty, covenant and other agreement contained in
this Agreement. In each Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed by the
Company in respect of any quarter in which sales of Shares were made by or through the Agent under
this Agreement (each date on which any such document is filed, and any date on which an amendment
to any such document is filed, a “Company Periodic Report Date”), the Company shall set
forth with regard to such quarter the number of Shares sold through the Agent under this Agreement,
the Net Proceeds received by the Company and the compensation paid by the Company to the Agent with
respect to sales of Shares pursuant to this Agreement.



(j) (A) Upon commencement of the offering of Shares under this Agreement, each Suspension
Termination Date, and, (B) except during any period in which the offering of Shares is suspended
pursuant to Section 2(c), (x) once weekly during the term of this Agreement on such day(s) as may
be agreed upon by the Company and the Agent following commencement of the offering of Shares under
this Agreement, and (y) promptly after each (i) date the Registration Statement or the Prospectus
shall be amended or supplemented (other than (1) by an amendment or supplement providing solely for
the determination of the terms of the Shares, (2) in connection with the filing of any current
reports on Form 8-K (other than any current reports on Form 8-K which contain financial statements,
supporting schedules or other financial data, including any current report on Form 8-K under Item
2.02 of such form that is considered “filed” under the 1934 Act) or (3) by a prospectus supplement
relating to the offering of other securities (including, without limitation, other shares of Common
Stock)) (each such date, a “Registration Statement Amendment Date”), (ii) date on which a
current report on Form 8-K shall be furnished by the Company under Item 2.02 of such form in
respect of a public disclosure or material non-public information regarding the Company’s results
of operations or financial condition for a completed quarterly or annual fiscal period (a
“Company Earnings Report Date”) and (iii) Company Periodic Report Date, the Company will
furnish or cause to be furnished forthwith to the Agent a certificate dated the date of
effectiveness of such amendment or the date of filing with the Commission of such supplement or
other document, as the case may be, or the date of delivery in the case of (A) and (B)(x), in a
form reasonably satisfactory to the Agent to the effect that the statements contained in the
certificate referred to in Section 6(e) of this Agreement which were last furnished to the Agent
are true and correct at the time of such amendment, supplement or filing, as the case may be, as
though made at and as of such time (except that such statements shall be deemed to relate to the
Registration Statement, the General Disclosure Package and the Prospectus as amended and
supplemented, or to the document incorporated by reference into the Prospectus, to such time) or,
in lieu of such certificate, a certificate of the same tenor as the certificate referred to in said
Section 6(e), but modified as necessary to relate to the Registration Statement, the General
Disclosure Package and the Prospectus as amended and supplemented, or to the document incorporated
by reference into the Prospectus, to the time of delivery of such certificate. As used in this
paragraph, to the extent there shall be an Applicable Time on or following the date referred to in
clause (i), (ii) or (iii) of (B)(y) above, “promptly” shall be deemed to be on or prior to the next
succeeding Applicable Time.



(k) (A) Upon commencement of the offering of Shares under this Agreement, each Suspension
Termination Date, and, (B) except during any period the offering of Shares is suspended pursuant to
Section 2(c), promptly after each (i) Registration Statement Amendment Date, (ii) Company Earnings
Report Date and (iii) Company Periodic Report Date, the Company will furnish or cause to be
furnished to the Agent and to counsel to the Agent the written opinion and letter of each Company
Counsel or other counsel reasonably satisfactory to the Agent, dated the date of effectiveness of
such amendment or the date of filing with the Commission of such supplement or other document, as
the case may be, or the date of delivery in the case of (A), in a form and substance reasonably
satisfactory to the Agent and its counsel, of the same tenor as the opinions and letters referred
to in Section 6(c) of this Agreement, but modified as necessary to relate to the Registration
Statement, the General Disclosure Package and the Prospectus as amended and supplemented, or to the
document incorporated by reference into the Prospectus, to the time of delivery of such opinion and
letter or, in lieu of such opinion and letter, counsel last furnishing such letter to the Agent
shall furnish such Agent with a letter substantially to the effect that the Agent may rely on such
last opinion and letter to the same extent as though each were dated the date of such letter
authorizing reliance (except that statements in such last letter shall be deemed to relate to the
Registration Statement, the General Disclosure Package and the Prospectus as amended and
supplemented, or to the document incorporated by reference into the Prospectus, to the time of
delivery of such letter authorizing reliance). As used in this paragraph, to the extent there shall
be an Applicable Time on or following the date referred to in clause (B)(i), (ii) or (iii) above,
“promptly” shall be deemed to be on or prior to the next succeeding Applicable Time.



(l) (A) Upon commencement of the offering of Shares under this Agreement, each Suspension
Termination Date, and, (B) except during any period the offering of Shares is suspended pursuant to
Section 2(c), promptly after each (i) Registration Statement Amendment Date, (ii) Company Earnings
Report Date and (iii) Company Periodic Report Date, the Company will cause KPMG LLP, or other
independent accountants reasonably satisfactory to the Agent, to furnish to the Agent a letter,
dated the date of effectiveness of such amendment or the date of filing of such supplement or other
document with the Commission, as the case may be, or the date of delivery in the case of (A), in
form reasonably satisfactory to the Agent and its counsel, of the same tenor as the letter referred
to in Section 6(d) hereof, but modified as necessary to relate to the Registration Statement, the
General Disclosure Package and the Prospectus, as amended and supplemented, or to the document
incorporated by reference into the Prospectus, to the date of such letter. As used in this
paragraph, to the extent there shall be an Applicable Time on or following the date referred to in
clause (B)(i), (ii) or (iii) above, “promptly” shall be deemed to be on or prior to the next
succeeding Applicable Time.



(m) During any Blackout Period in which the Company requests the sale of Shares pursuant to
this Agreement, the Company will furnish upon the request of the Agent, prior to such sale, those
documents referred to in Sections 3(j), (k) and (l).



(n) The Company consents to the Agent trading in the Company’s Common Stock for the Agent’s
own account and for the account of its clients at the same time as sales of Shares occur pursuant
to this Agreement.



(o) If, to the knowledge of the Company, all filings required by Rule 424 in connection with
this offering shall not have been made or the representations in Section 1(a) shall not be true and
correct on the applicable Settlement Date, the Company will offer to any person who has agreed to
purchase Shares from the Company as the result of an offer to purchase solicited by the Agent the
right to refuse to purchase and pay for such Shares.



(p) The Company will cooperate timely with any reasonable due diligence review conducted by
the Agent or its counsel at such times as contemplated by this Agreement in connection with the
transactions contemplated hereby, including, without limitation, and upon reasonable notice
providing information and making available documents and appropriate corporate officers, during
regular business hours and at the Company’s principal offices, as the Agent may reasonably request.



(q) The Company will not, without (i) giving the Agent at least five business days’ prior
written notice specifying the nature of the proposed sale and the date of such proposed sale and
(ii) the Agent suspending activity under this program for such period of time as requested by the
Company or as deemed appropriate by the Agent in light of the proposed sale, (A) offer, pledge,
announce the intention to sell, sell, contract to sell, sell any option or contract to purchase,
purchase any option or contract to sell, grant any option, right or warrant for the sale of, lend
or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or
securities convertible into or exchangeable or exercisable for or repayable with Common Stock, or
file any registration statement under the 1933 Act with respect to any of the foregoing (other than
a shelf registration statement under Rule 415 under the 1933 Act, a registration statement on Form
S-8 or post-effective amendment to the Registration Statement) or (B) enter into any swap or other
agreement or any transaction that transfers in whole or in part, directly or indirectly, any of the
economic consequence of ownership of the Common Stock, or any securities convertible into or
exchangeable or exercisable for or repayable with Common Stock, whether any such swap or
transaction described in clause (A) or (B) above is to be settled by delivery of Common Stock or
such other securities, in cash or otherwise. The foregoing sentence shall not apply to (v) the
Shares to be offered and sold through the Agent pursuant to this Agreement, (w) Common Stock
issuable pursuant to the Company’s dividend reinvestment plan as it may be amended or replaced from
time to time, (x) Common Stock issuable upon the conversion of the Company’s 5?% Cumulative
Convertible Perpetual Preferred Stock, Series D, (y) equity incentive awards approved by the board
of directors of the Company or the compensation committee thereof or the issuance of Common Stock
upon exercise thereof and (z) Common Stock sold pursuant to the Kansas City Southern 2009 Employee
Stock Purchase Plan as adopted by the Company’s Board of Directors on March 10, 2009.



(r) If immediately prior to the third anniversary (the “Renewal Deadline”) of the
initial effective date of the Registration Statement, any of the Shares remain unsold, the Company
will, prior to the Renewal Deadline file, if it has not already done so and is eligible to do so, a
new automatic shelf registration statement relating to the Shares, in a form reasonably
satisfactory to the Agent. If the Company is no longer eligible to file an automatic shelf
registration statement, the Company will, prior to the Renewal Deadline, if it has not already done
so, file a new shelf registration statement relating to the Shares, in a form reasonably
satisfactory to the Agent, and will use its best efforts to cause such registration statement to be
declared effective within 60 days after the Renewal Deadline. The Company will take all other
action necessary or appropriate to permit the issuance and sale of the Shares to continue as
contemplated in the expired registration statement relating to the Shares. References herein to
the Registration Statement shall include such new automatic shelf registration statement or such
new shelf registration statement, as the case may be.



Section 4. Free Writing Prospectus.




(a)      (i) The Company represents and agrees that without the prior consent of the Agent,
it has not made and will not make any offer relating to the Shares that would constitute a
“free writing prospectus” as defined in Rule 405 under the 1933 Act; and




(ii) the Agent represents and agrees that, without the prior consent of the Company it
has not made and will not make any offer relating to the Shares that would constitute a free
writing prospectus required to be filed with the Commission.



(b) The Company has complied and will comply with the requirements of Rule 433 under the 1933
Act applicable to any Issuer Free Writing Prospectus (including any free writing prospectus
identified in Section 4(a) hereof), including timely filing with the Commission or retention where
required and legending.



Section 5. Payment of Expenses.



(a) The Company covenants and agrees with the Agent that the Company will pay or cause to be
paid the following: (i) the fees, disbursements and expenses of the Company’s counsel and
accountants in connection with the registration of the Shares under the 1933 Act and all other
expenses in connection with the preparation, printing and filing of the Registration Statement, the
Basic Prospectus, Prospectus Supplement, any Issuer Free Writing Prospectus and the Prospectus and
amendments and supplements thereto and the mailing and delivering of copies thereof to the Agents;
(ii) the cost of printing or producing this Agreement, any Blue Sky and Legal Investment Memoranda,
closing documents (including any compilations thereof) and any other documents in connection with
the offering, purchase, sale and delivery of the Shares; (iii) all expenses in connection with the
qualification of the Shares for offering and sale under state securities laws as provided in
Section 3(b) hereof; (iv) any filing fees incident to any required review by Financial Industry
Regulatory Authority, Inc. of the terms of the sale of the Shares; (v) all fees and expenses in
connection with listing the Shares on the Exchange; (vi) the cost of preparing the Shares; (vii)
the costs and charges of any transfer agent or registrar or any dividend distribution agent; and
(viii) all other costs and expenses incident to the performance of its obligations hereunder which
are not otherwise specifically provided for in this Section; provided, however, if
a number of Shares having an aggregate offering price in excess of $50,000,000 have been offered
and sold under this Agreement by April 27, 2010, the Agent shall reimburse the Company up to
$187,500 of the Company’s expenses. It is understood, however, that, except as provided in this
Section, and Section 7 hereof, the Agent will pay all of its own costs and expenses, including the
fees of its counsel, transfer taxes on resale of any of the Shares by it, and any advertising
expenses connected with any offers it may make.



(b) If a number of Shares having an aggregate offering price of $15,000,000 have not been
offered and sold under this Agreement by April 27, 2010 (or such earlier date on which the Company
terminates this Agreement), the Company shall reimburse the Agent for all of its reasonable
out-of-pocket expenses, including the reasonable fees and disbursements of a single counsel for the
Agent incurred by it in connection with the offering contemplated by this Agreement.



Section 6. Conditions of Agent’s Obligation. The obligations of the Agent hereunder
shall be subject, in its reasonable discretion, to the condition that all representations and
warranties and other statements of the Company herein or in certificates of any officer of the
Company delivered pursuant to the provisions hereof are true and correct as of the time of the
execution of this Agreement, as of each Suspension Termination Date, Applicable Time and Settlement
Date and, except during any period the offering of Shares is suspended pursuant to Section 2(c), as
of each Registration Statement Amendment Date, Company Periodic Report Date and Company Earnings
Report Date, to the condition that the Company shall have performed all of its obligations
hereunder theretofore to be performed, and to the following additional conditions:



(a) The Prospectus Supplement shall have been filed with the Commission pursuant to Rule
424(b) under the 1933 Act on or prior to the date hereof and in accordance with Section 3(a)
hereof, any other material required to be filed by the Company pursuant to Rule 433(d) under the
1933 Act shall have been filed with the Commission within the applicable time periods prescribed
for such filings by Rule 433; no stop order suspending the effectiveness of the Registration
Statement or any part thereof shall have been issued and no proceeding for that purpose shall have
been initiated or threatened by the Commission and no notice of objection of the Commission to the
use of the form of the Registration Statement or any post-effective amendment thereto pursuant to
Rule 401(g)(2) under the 1933 Act shall have been received; no stop order suspending or preventing
the use of the Prospectus or any Issuer Free Writing Prospectus shall have been initiated or
threatened by the Commission; and all requests for additional information on the part of the
Commission shall have been complied with to the reasonable satisfaction of the Agent.



(b) On every date specified in Section 3(k) hereof and as may be requested by the Agent with
respect to any sale of Shares during a Blackout Period, Shearman & Sterling LLP, counsel for the
Agent, shall have furnished to the Agent such written opinion or opinions, dated as of such date,
with respect to such matters as the Agent may reasonably request, and such counsel shall have
received such papers and information as they may reasonably request to enable them to pass upon
such matters.



(c) On every date specified in Section 3(k) hereof, Sonnenschein Nath & Rosenthal LLP, counsel
for the Company, shall have furnished to the Agent written opinion or opinions, dated as of such
date, in form and substance reasonably satisfactory to the Agent, to the effect set forth in Annex
I hereto.



(d) At the dates specified in Section 3(l) hereof, the independent accountants of the Company
who have certified the financial statements of the Company and its subsidiaries included or
incorporated by reference in the Registration Statement shall have furnished to the Agent a letter
dated as of the date of delivery thereof and addressed to the Agent in form and substance
reasonably satisfactory to the Agent and its counsel, containing statements and information of the
type ordinarily included in accountants’ “comfort letters” to underwriters with respect to the
financial statements of the Company and its subsidiaries included or incorporated by reference in
the Registration Statement.



(e) (i) Upon commencement of the offering of Shares under this Agreement, the Company will
furnish or cause to be furnished promptly to the Agent a certificate of an officer in a form
reasonably satisfactory to the Agent stating the minimum price for the sale of such Shares pursuant
to this Agreement and the maximum number of Shares that may be issued and sold pursuant to this
Agreement or, alternatively, maximum gross proceeds from such sales, as authorized from time to
time by the Company’s board of directors or a duly authorized committee thereof or, in connection
with any amendment, revision or modification of such minimum price or maximum Share number or
amount, a new certificate with respect thereto and (ii) on each date specified in Section 3(j), the
Agent shall have received a certificate of executive officers of the Company, one of whom shall be
the Chief Financial Officer, Chief Accounting Officer, Treasurer, or Executive Vice President in
the area of capital markets and investments, dated as of the date thereof, to the effect that (A)
there has been no Material Adverse Effect since the date as of which information is given in the
Prospectus as then amended or supplemented, (B) the representations and warranties in Section 1
hereof are true and correct as of such date and (C) the Company has complied with all of the
agreements entered into in connection with the transaction contemplated herein and satisfied all
conditions on its part to be performed or satisfied.



(f) Since the date of the latest audited financial statements then included or incorporated by
reference in the Prospectus and the General Disclosure Package, no Material Adverse Effect shall
have occurred.



(g) The Company shall have complied with the provisions of Section 3(c) hereof with respect to
the timely furnishing of prospectuses.



(h) The Company shall have conducted due diligence sessions, in form and substance reasonably
satisfactory to the Agent (i) on such dates as requested by the Agent during any Blackout Period in
which the Company requests the sale of Shares pursuant to this Agreement and (ii) once weekly
during the term of this Agreement following commencement of the offering of Shares under this
Agreement on such day(s) as may be agreed upon by the Company and the Agent.



(i) With respect to any sale of Shares during a Blackout Period, the Company shall have
furnished those documents requested by the Agent pursuant to Section 3(m).



(j) All filings with the Commission required by Rule 424 under the 1933 Act to have been filed
by each Applicable Time or related Settlement Date shall have been made within the applicable time
period prescribed for such filing by Rule 424 (without reliance on Rule 424(b)(8)).



(k) The Shares shall have received approval for listing on the NYSE prior to the first
Settlement Date.



Section 7. Indemnification.



(a) The Company will indemnify and hold harmless the Agent against any losses, claims, damages
or liabilities, joint or several, to which the Agent may become subject, under the 1933 Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon an untrue statement or alleged untrue statement of a material fact
contained in the Registration Statement, the Basic Prospectus, the Prospectus Supplement or the
Prospectus or any amendment or supplement thereto, any Issuer Free Writing Prospectus or any
“issuer information” filed or required to be filed pursuant to Rule 433(d) under the 1933 Act, or
arise out of or are based upon the omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statements therein not misleading, and will
reimburse the Agent for any legal or other expenses reasonably incurred by the Agent in connection
with investigating or defending any such action or claim as such expenses are incurred;
provided, however, that the Company shall not be liable in any such case to the
extent that any such loss, claim, damage or liability arises out of or is based upon an untrue
statement or alleged untrue statement or omission or alleged omission made in the Registration
Statement, the Basic Prospectus, the Prospectus Supplement or the Prospectus, or any amendment or
supplement thereto, or any Issuer Free Writing Prospectus, in reliance upon and in conformity with
written information furnished to the Company by the Agent expressly for use therein.



(b) The Agent will indemnify and hold harmless the Company against any losses, claims, damages
or liabilities to which the Company may become subject, under the 1933 Act or otherwise, insofar as
such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are
based upon an untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement, the Basic Prospectus, the Prospectus Supplement or the Prospectus, or any
amendment or supplement thereto, or any Issuer Free Writing Prospectus, or arise out of or are
based upon the omission or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading, in each case to the extent, but
only to the extent, that such untrue statement or alleged untrue statement or omission or alleged
omission was made in the Registration Statement, the Basic Prospectus, the Prospectus Supplement or
the Prospectus, or any such amendment or supplement thereto, or any Issuer Free Writing Prospectus,
in reliance upon and in conformity with written information furnished to the Company by the Agent
expressly for use therein; and will reimburse the Company for any legal or other expenses
reasonably incurred by the Company in connection with investigating or defending any such action or
claim as such expenses are incurred.



(c) Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice
of the commencement of any action, such indemnified party shall, if a claim in respect thereof is
to be made against the indemnifying party under such subsection, notify the indemnifying party in
writing of the commencement thereof; but the omission so to notify the indemnifying party shall not
relieve it from any liability which it may have to any indemnified party otherwise than under such
subsection except and then only to the extent such indemnifying party is materially prejudiced
thereby. In case any such action shall be brought against any indemnified party and it shall notify
the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to
participate therein and, to the extent that it shall wish, jointly with any other indemnifying
party similarly notified, to assume the defense thereof, with counsel satisfactory to such
indemnified party (who shall not, except with the consent of the indemnified party, be counsel to
the indemnifying party), and, after notice from the indemnifying party to such indemnified party of
its election so to assume the defense thereof, the indemnifying party shall not be liable to such
indemnified party under this Section 7 for any legal expenses of other counsel or any other
expenses, in each case subsequently incurred by such indemnified party, in connection with the
defense thereof other than reasonable costs of investigation. No indemnifying party shall, without
the written consent of the indemnified party, effect the settlement or compromise of, or consent to
the entry of any judgment with respect to, any pending or threatened action or claim in respect of
which indemnification or contribution may be sought hereunder (whether or not the indemnified party
is an actual or potential party to such action or claim) unless such settlement, compromise or
judgment (i) includes an unconditional release of the indemnified party from all liability arising
out of such action or claim and (ii) does not include a statement as to or an admission of fault,
culpability or a failure to act, by or on behalf of any indemnified party.



(d) If the indemnification provided for in this Section 7 is unavailable to hold harmless an
indemnified party under subsection (a) or (b) above in respect of any losses, claims, damages or
liabilities (or actions in respect thereof) referred to therein, then each indemnifying party shall
contribute to the amount paid or payable by such indemnified party as a result of such losses,
claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate
to reflect the relative benefits received by the Company on the one hand and the Agent on the other
from the offering of the Shares to which such loss, claim, damage or liability (or action in
respect thereof) relates. If, however, the allocation provided by the immediately preceding
sentence is not permitted by applicable law, then each indemnifying party shall contribute to such
amount paid or payable by such indemnified party in such proportion as is appropriate to reflect
not only such relative benefits but also the relative fault of the Company on the one hand and the
Agent on the other in connection with the statements or omissions which resulted in such losses,
claims, damages or liabilities (or actions in respect thereof), as well as any other relevant
equitable considerations. The relative benefits received by the Company on the one hand and the
Agent on the other shall be deemed to be in the same proportion as the total net proceeds from the
offering (before deducting expenses) received by the Company bear to the total commissions received
by the Agent. The relative fault shall be determined by reference to, among other things, whether
the untrue or alleged untrue statement of a material fact or the omission or alleged omission to
state a material fact relates to information supplied by the Company on the one hand or the Agent
on the other and the parties’ relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission. The Company and the Agent agree that it would not
be just and equitable if contribution pursuant to this subsection (d) were determined by pro rata
allocation (even if the Agent was treated as one entity for such purpose) or by any other method of
allocation which does not take account of the equitable considerations referred to above in this
subsection (d). The amount paid or payable by an indemnified party as a result of the losses,
claims, damages or liabilities (or actions in respect thereof) referred to above in this subsection
(d) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any such action or claim. Notwithstanding the
provisions of this subsection (d), the Agent shall not be required to contribute any amount in
excess of the amount by which the total price at which the Shares sold by it to the public were
offered to the public exceeds the amount of any damages which the Agent has otherwise been required
to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No
person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act)
shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation.



(e) The obligations of the Company under this Section 7 shall be in addition to any liability
which the Company may otherwise have and shall extend, upon the same terms and conditions, to the
directors and officers of the Agent and to each person, if any, who controls the Agent within the
meaning of the 1933 Act and each broker dealer affiliate of the Agent; and the obligations of the
Agent under this Section 7 shall be in addition to any liability which the Agent may otherwise have
and shall extend, upon the same terms and conditions, to each officer and director of the Company
and to each person, if any, who controls the Company within the meaning of the 1933 Act.



Section 8. Representations, Warranties and Agreements to Survive Delivery. The
respective indemnities, agreements, representations, warranties and other statements of the Company
and the Agent, as set forth in this Agreement or made by or on behalf of them, respectively,
pursuant to this Agreement, shall remain in full force and effect, regardless of any investigation
(or any statement as to the results thereof) made by or on behalf of the Agent or any controlling
person of the Agent, or the Company, or any officer or director or controlling person of the
Company, and shall survive delivery of and payment for the Shares.



Section 9. No Advisory or Fiduciary Relationship. The Company acknowledges and
agrees that (i) the Agent is acting solely in the capacity of an arm’s length contractual
counterparty to the Company with respect to the offering of Shares contemplated hereby (including
in connection with determining the terms of such offering) and (ii) the Agent has not assumed an
advisory or fiduciary responsibility in favor of the Company with respect to the offering
contemplated hereby or the process leading thereto (irrespective of whether the Agent has advised
or is currently advising the Company on other matters) or any other obligation to the Company
except the obligations expressly set forth in this Agreement and (iii) the Company has consulted
its own legal and financial advisors to the extent it deemed appropriate. The Company agrees that
it will not claim that the Agent has rendered advisory services of any nature or respect, or owes a
fiduciary or similar duty to the Company, in connection with such transaction or the process
leading thereto.



Section 10. Termination.



(a) The Company shall have the right, by giving written notice as hereinafter specified, to
terminate this Agreement in its sole discretion at any time. Any such termination shall be without
liability of any party to any other party, except that (i) with respect to any pending sale through
the Agent for the Company, the obligations of the Company, including in respect of compensation of
the Agent, shall remain in full force and effect notwithstanding such termination; and (ii) the
provisions of Section 1, Section 5(b), Section 7 and Section 8 of this Agreement shall remain in
full force and effect notwithstanding such termination.



(b) The Agent shall have the right, by giving written notice as hereinafter specified, to
terminate this Agreement in its sole discretion at any time. Any such termination shall be without
liability of any party to any other party except that the provisions of Section 1, Section 7 and
Section 8 of this Agreement shall remain in full force and effect notwithstanding such termination.



(c) This Agreement shall remain in full force and effect until and unless terminated pursuant
to Section 10(a) or (b) above or otherwise by mutual agreement of the parties; provided
that any such termination by mutual agreement or pursuant to this clause (c) shall in all cases be
deemed to provide that Section 1, Section 7 and Section 8 of this Agreement shall remain in full
force and effect.



(d) Any termination of this Agreement shall be effective on the date specified in such notice
of termination; provided that such termination shall not be effective until the close of
business on the date of receipt of such notice by the Agent or the Company, as the case may be. If
such termination shall occur prior to the Settlement Date for any sale of Shares, such sale shall
settle in accordance with the provisions of Section 2(h) hereof.



Section 11. Notices. All statements, requests, notices and agreements hereunder
shall be in writing, and if to the Agent shall be delivered or sent by mail, telex or facsimile
transmission to:




Merrill, Lynch, Pierce, Fenner & Smith Incorporated


4 World Financial Center


New York, New York 10080


Fax No. (212) 449-0355


Attention: Charles Hill,




and if to the Company to:




Kansas City Southern


P.O. Box 219335


Kansas City, MO 64105 64121-9335


Telecopy No.: 816-983-1198


Attention: Senior Vice President-Finance and Treasurer.



Any such statements, requests, notices or agreements shall take effect upon receipt thereof.



Section 12. Parties. This Agreement shall be binding upon, and inure solely to the
benefit of, the Agent and the Company and, to the extent provided in Sections 7 and 8 hereof, the
officers and directors of the Company and the Agent and each person who controls the Company or the
Agent, and their respective heirs, executors, administrators, successors and assigns, and no other
person shall acquire or have any right under or by virtue of this Agreement. No purchaser of
Shares through the Agent shall be deemed a successor or assign by reason merely of such purchase.



Section 13. Time of the Essence. Time shall be of the essence of this Agreement. As
used herein, the term “business day” shall mean any day when the Commission’s office in Washington,
D.C. is open for business.



Section 14. Waiver of Jury Trial. The Company and the Agent hereby irrevocably
waive, to the fullest extent permitted by applicable law, any and all right to jury trial by jury
in any legal proceeding arising out of or relating to this Agreement or the transactions
contemplated hereby.



Section 15. Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REFERENCE TO ITS PRINCIPLES OF CONFLICTS
OF LAW.



Section 16. Counterparts. This Agreement may be executed by any one or more of the
parties hereto and thereto in any number of counterparts, each of which shall be deemed to be an
original, but all such respective counterparts shall together constitute one and the same
instrument. This Agreement may be delivered by any party by facsimile or other electronic
transmission.



Section 17. Severability. The invalidity or unenforceability of any Section,
paragraph or provision of this Agreement shall not affect the validity or enforceability of any
other Section, paragraph or provision hereof. If any Section, paragraph or provision of this
Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be
made such minor changes (and only such minor changes) as are necessary to make it valid and
enforceable.



If the foregoing is in accordance with your understanding of our agreement, please sign and
return to the Company a counterpart hereof, whereupon this instrument, along with all counterparts,
will become a binding agreement between the Agent and the Company in accordance with its terms.



Very truly yours,



Kansas City Southern



By: /s/ Michael W. Upchurch      

Name: Michael W. Upchurch

Title: Executive Vice President and Chief

Financial Officer




Accepted as of the date hereof:



Merrill Lynch, Pierce, Fenner & Smith Incorporated



By: /s/ Matthew A. Thomson      

Name: Matthew A. Thomson

Title: Director




Annex I




Form of Opinion of Company Counsel




(1) The Registration Statement became effective automatically under the 1933 Act as of November 21,
2008; the Prospectus was filed pursuant to Rule 424(b); the Company is not an “ineligible issuer”
in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the 1933 Act
and the Company is well-known seasoned issuer (as defined in Rule 405 under the 1933 Act) eligible
to use the Registration Statement as an automatic shelf registration statement. No order
suspending the effectiveness of the Registration Statement has been issued and no proceeding for
that purpose against the Company is pending or, to our knowledge, threatened by the Commission.



(2) Each of the documents incorporated by reference in the Registration Statement, the General
Disclosure Package and the Prospectus (other than the financial statements, including footnotes to
the financial statements and related schedules, and any other statistical data included or
incorporated in the Registration Statement, the General Disclosure Package or the Prospectus, as to
which we express no opinion) when they became effective or were filed with the Commission, as the
case may be, appeared on its face to be appropriately responsive as of its filing date in all
material respects to the requirements of the 1933 Act or the 1934 Act, as applicable, and the rules
and regulations of the Commission thereunder.



(3) Each of the Registration Statement and the Prospectus and each Issuer Free Writing Prospectus
(other than the financial statements, including footnotes to the financial statements and related
schedules, and any other statistical data included or incorporated in the Registration Statement or
the Prospectus, as to which we express no opinion) appeared on its face to be appropriately
responsive as of its filing date in all material respects to the requirements of the 1933 Act.



(4) The Company has been duly incorporated, is validly existing as a corporation and is duly
qualified to transact business and is in good standing in each jurisdiction indicated on Schedule I
to this opinion and has the corporate power and authority to own, lease and operate its property
and to conduct its business as described in the Prospectus.



(5) Each subsidiary of the Company has been duly organized, is validly existing and is duly
qualified to transact business and in good standing (to the extent applicable) in each jurisdiction
indicated on Schedule I to this opinion and has the corporate power and authority to own, lease and
operate its property and to conduct its business as described in the Prospectus.



(6) All of the issued shares of capital stock of each corporate subsidiary of the Company that is
held by the Company have been duly and validly authorized and issued and are fully paid and
nonassessable.



(7) The Sales Agreement has been duly authorized, executed and delivered by the Company.



(8) The authorized capital stock and capitalization of the Company conforms as to legal matters to
the description thereof contained in the Prospectus, and the shares of issued and outstanding
capital stock set forth thereunder have been duly authorized and validly issued and are fully-paid
an non-assessable, and were not issued in violation of the preemptive or other similar rights of
any securityholder of the Company.



(9) The Shares have been duly authorized and reserved for issuance and sale pursuant to the Sales
Agreement and, when issued and delivered by the Company pursuant to the Sales Agreement against
payment of the consideration set forth therein, will be validly issued and fully paid and
non-assessable.



(10) The execution, delivery and performance by the Company of its obligations under the Sales
Agreement, and consummation of the transactions contemplated therein, in each case (i) has been
duly authorized by the Company; and (ii) does not and will not (a) contravene, conflict with,
violate or give rise to a breach of, or default under, any agreement or other instrument binding
upon the Company or any of its subsidiaries that is included or incorporated by reference into the
Annual Report on Form 10-K for the year ended December 31, 2008 filed by the Company, (b) result in
an event or condition which will give the holder of any note, debenture, or other evidence of
indebtedness that is included or incorporated by reference into the Annual Report on Form 10-K for
the year ended December 31, 2008 filed by the Company (or any person acting on their behalf), the
right to require the repurchase, redemption or repayment of all or any portion of any amounts due
in respect of such indebtedness by the Company, (c) violate any statute, rule or regulation of the
United States or New York, or (d) to our knowledge, violate any judgment, order, or decree of any
court or arbitrator or governmental agency or body of the United States or the State of New York
having jurisdiction over the Company or any of its subsidiaries or any of their properties or
assets, except for violations that would not have a material adverse effect on the Company and its
subsidiaries, taken as a whole.



(11) No consent, approval, authorization or order of, or filing, qualification or registration
with, any court, arbitrator or governmental agency or body of the United States or the State of New
York having jurisdiction over the Company is required for the performance by the Company of its
obligations under the Sales Agreement, except for such consents, approvals, authorizations,
filings, registrations or qualifications (i) which have been obtained or made prior to the date
hereof and (ii) as may be required to be obtained or made under the 1933 Act and applicable state
securities laws in connection with the offer and sale of the Shares, as to which we express no
opinion.



(12) To our knowledge, there are no legal or governmental proceedings pending or threatened to
which the Company or any of its subsidiaries is party or which any of the properties of the Company
or any of its subsidiaries is subject that would be required to be disclosed in the Registration
Statement but are not so disclosed or incorporated by reference therein, other than proceedings
fairly summarized in all material respects in the Registration Statement, or incorporated by
reference therein.



(13) The Company is not, and, after giving effect to the offering and sale of the Shares and the
application of the proceeds thereof as described in the Prospectus, will not be, an investment
company as such term is defined in the Investment Company Act of 1940, as amended.



(14) The Shares have been approved for listing on the NYSE, subject to official notice of issuance.



(15) The statements in the Registration Statement, the General Disclosure Package and the
Prospectus under the heading “Certain U.S. Federal Income Tax Considerations,” insofar as such
statements constitute matters of U.S. federal income tax law and purport to summarize matters of
law or legal conclusions with respect thereto, are fair summaries in all material respects.



The primary purpose of our engagement was not to establish or confirm factual matters or
financial or accounting matters and we have not independently verified the accuracy, completeness
or fairness of the statements made or included in the Registration Statement, General Disclosure
Package and the Prospectus and any amendments or supplements thereto (including any documents
incorporated by reference or deemed to be incorporated by reference therein), and we take no
responsibility therefor, except as and to the extent set forth in numbered paragraphs 8, 12 and 15
of our opinion set forth above in this letter. In connection with our engagement, we have
participated in conferences with officers and other representatives of the Company, of the
registered public accounting firm of the Company, and you and your counsel and representatives of
the Agent, at which the contents of the Registration Statement, the General Disclosure Package and
the Prospectus and any amendments or supplements thereto (including any documents incorporated by
reference or deemed to be incorporated by reference therein) and related matters were discussed,
and based upon such participation and discussions, and relying upon our judgment as to materiality
based upon the factual statements of officers and other representatives of the Company, no facts
have come to our attention that have led us to believe that (i) the Registration Statement, at the
time of its effective date (including the information, if any, deemed pursuant to Rule 430B to be
part of the Registration Statement at the time of effectiveness), or on the date hereof, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary to make the statements therein not misleading, (ii) that the General
Disclosure Package, as of the date hereof, contained any untrue statement of a material fact or
omitted to state a material fact necessary to make the statements therein not misleading or (iii)
that the Prospectus, as of its date and as of the date hereof, contains any untrue statement of a
material fact or omits to state a material fact necessary to make the statements therein in the
light of the circumstances under which they were made not misleading (except, in each case, for the
financial statements, including footnotes to the financial statements and related schedules, and
any other statistical data included or incorporated by reference therein, as to which we make no
statement).



1



Exhibit A




Form of Electronic Communication Specified in Section 2(j)




Please confirm that the Prospectus (including the documents incorporated by reference therein), as
of the date of this email, does not contain an untrue statement of a material fact or omit to state
a material fact necessary in order to make the statements therein, in the light of the
circumstances under which there were made, not misleading.



Officers Initially Designated by the Company for Purposes of Section 2(j)




	 	 	 
	Michael W. Upchurch

Paul J. Weyandt

William J. Wochner

	 	(mupchurch@kcsouthern.com)

(pweyandt@kcsouthern.com)

(jwochner@kcsouthern.com)







2